SCHEMBL7063409

SCHEMBL7063409

CC(C)(C)[Si](C)(C)Oc1ccc([C@H]2CC[C@H](N(O)C(=O)c3ccccc3)CC2)c(O[Si](C)(C)C(C)(C)C)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.35
HSP90AB1 P08238 1/20 0.35
HSD11B1 P28845 1/20 0.34
SLC6A9 P48067 1/20 0.33
CA12 O43570 3/20 0.33
CA1 P00915 3/20 0.33
CA9 Q16790 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
CNR2 P34972 2/20 0.32
MRGPRX4 Q96LA9 1/20 0.32
LMNA P02545 1/20 0.31
TSHR P16473 1/20 0.31
ELANE P08246 1/20 0.31
SLC22A12 Q96S37 1/20 0.31
PREP P48147 1/20 0.31
CHRM2 P08172 1/20 0.31
CHRM3 P20309 1/20 0.31
CCR2 P41597 1/20 0.30
GPR119 Q8TDV5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7063406 1.00 HSP90AA1 (0.35) HSP90AA1HSP90AB1HSD11B1SLC6A9CA12
SCHEMBL6806719 0.82 HSP90AA1 (0.35) HSP90AA1HSP90AB1CA12CA1CA9
SCHEMBL6806711 0.82 HSP90AA1 (0.35) HSP90AA1HSP90AB1CA12CA1CA9
SCHEMBL7062206 0.81 ELANE (0.35) HSP90AA1HSP90AB1KMT2AMRGPRX4ELANE
SCHEMBL7062208 0.81 ELANE (0.35) HSP90AA1HSP90AB1KMT2AMRGPRX4ELANE
SCHEMBL7063724 0.80 NPC1 (0.47) MEN1KMT2A
SCHEMBL7063726 0.80 NPC1 (0.47) MEN1KMT2A
SCHEMBL7064802 0.80 MRGPRX4 (0.35) HSP90AA1HSP90AB1SLC6A9MEN1KMT2A
SCHEMBL7062211 0.80 MRGPRX4 (0.35) HSP90AA1HSP90AB1SLC6A9MEN1KMT2A
SCHEMBL7653405 0.80 MRGPRX4 (0.35) HSP90AA1HSP90AB1SLC6A9MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6797731-B2 USE AS SKIN LIGHTENING AGENTS PFIZER INC. 2004-09-28 US disclosed
US-20030190298-A1 Resorcinol derivatives BRADLEY STUART E (GB) 2003-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030190298-A1 Resorcinol derivatives LRAT, NQO1, ALDH1A2 HSP90AA1 1266/4885HSP90AB1 1208/4885HSD11B1 347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.